SCHEMBL23546397

SCHEMBL23546397

CCc1c(Cl)c(C)cc2c1cnn2C1CCCCO1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 2/20 0.43
▸ CYP4A11 Q02928 2/20 0.43
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ RXRG P48443 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ PDE4D Q08499 1/20 0.35
▸ PDE1A P54750 8/20 0.35
▸ PDE1B Q01064 8/20 0.35
▸ PDE1C Q14123 8/20 0.35
▸ KRAS P01116 1/20 0.35
▸ ATR Q13535 1/20 0.35
▸ PDE9A O76083 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ YTHDC1 Q96MU7 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ DGAT2 Q96PD7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25896636 0.84 CYP4F2 (0.39) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL21196042 0.83 CYP4F2 (0.47) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL29563445 0.83 CYP4F2 (0.42) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL21196104 0.83 CYP4F2 (0.42) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL29563167 0.83 CYP4F2 (0.40) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL24460667 0.83 CYP4F2 (0.40) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL22554881 0.81 CYP4F2 (0.41) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL24779651 0.81 CYP4F2 (0.41) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL31127858 0.81 RXRA (0.41) CYP4F2CYP4A11RXRARXRBRXRG
SCHEMBL30959607 0.81 CYP4F2 (0.42) CYP4F2CYP4A11RXRARXRBRXRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021124222-A1 PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-06-24 — — WO disclosed
Send feedback